STEPHANIE SCHMID: Open Payments
NPI 1750876587 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 47 payments from 16 companies in 2025. Trend: 2023 $597 · 2024 $668 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $151 |
| ABBVIE INC. | 4 | $82 |
| Exact Sciences Corporation | 3 | $58 |
| Abbott Laboratories | 2 | $34 |
| Novo Nordisk Inc | 2 | $34 |
| PFIZER INC. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Ascensia Diabetes Care Us Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: OTEZLA, BREZTRI, VRAYLAR, AIRSUPRA, Cologuard Collection Kit, EVENITY, FREESTYLE LIBRE 3, Rybelsus.
Industry payments across AZ — which companies pay providers there.
